Logo image
Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder
Journal article   Peer reviewed

Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder

Jess G Fiedorowicz, David A Solomon, Jean Endicott, Andrew C Leon, Chunshan Li, John P Rice and William H Coryell
Psychosomatic medicine, Vol.71(6), pp.598-606
07/2009
DOI: 10.1097/psy.0b013e3181acee26
PMCID: PMC2779721
PMID: 19561163
url
http://doi.org/10.1097/PSY.0b013e3181acee26View
Open Access

Abstract

To compare the risk for cardiovascular mortality between bipolar I and bipolar II subtypes and determine correlates of cardiovascular mortality. Bipolar disorder conveys an increased risk of cardiovascular mortality. Participants with major affective disorders were recruited for the National Institute of Mental Health Collaborative Depression Study and followed prospectively for up to 25 years. A total of 435 participants met the diagnostic criteria for bipolar I (n = 288) or bipolar II (n = 147) disorder based on Research Diagnostic Criteria at intake and measures of psychiatric symptoms during follow-up. Diagnostic subtypes were contrasted by cardiovascular mortality risk using Cox proportional hazards regression. Affective symptom burden (the proportion of time with clinically significant manic/hypomanic or depressive symptoms) and treatment exposure were additionally included in the models. Thirty-three participants died from cardiovascular causes. Participants with bipolar I disorder had more than double the cardiovascular mortality risk of those with bipolar II disorder, after controlling for age and gender (hazard ratio = 2.35, 95% Confidence Interval = 1.04-5.33; p = .04). The observed difference in cardiovascular mortality between these subtypes was at least partially confounded by the burden of clinically significant manic/hypomanic symptoms which predicted cardiovascular mortality independent of diagnosis, treatment exposure, age, gender, and cardiovascular risk factors at intake. Selective serotonin uptake inhibitors seemed protective although they were introduced late in follow-up. Depressive symptom burden was not related to cardiovascular mortality. Participants with bipolar I disorder may face a greater risk of cardiovascular mortality than those with bipolar II disorder. This difference in cardiovascular mortality risk may reflect manic/hypomanic symptom burden.
Prospective Studies Follow-Up Studies Humans Risk Factors Proportional Hazards Models Cost of Illness Male Bipolar Disorder - mortality Bipolar Disorder - diagnosis Cause of Death Bipolar Disorder - classification Psychiatric Status Rating Scales Cardiovascular Diseases - mortality Adult Female Longitudinal Studies Cohort Studies

Details

Metrics

Logo image